<?xml version='1.0' encoding='utf-8'?>
	<rss version='2.0'
		xmlns:content='http://purl.org/rss/1.0/modules/content/'
		xmlns:wfw='http://wellformedweb.org/CommentAPI/'
		xmlns:dc='http://purl.org/dc/elements/1.1/'
		xmlns:atom='http://www.w3.org/2005/Atom'
		xmlns:sy='http://purl.org/rss/1.0/modules/syndication/'
		xmlns:slash='http://purl.org/rss/1.0/modules/slash/'	
	>
	<channel><title>Latest Market Research Reports</title>	
	<description>Latest Market Research Reports XML feed</description>
	<language>en-us</language>			<item>
			<title>Point of Care Diagnostics Market</title>
			<link>https://www.reportsnreports.com/reports/7888845-point-of-care-diagnostics-market.html</link>
			<description><![CDATA[Recent Developments of Point of Care Diagnostics Industry:

In May 2023, bioM&eacute;rieux received the US FDA CLIA-waiver for the BIOFIRE SPOTFIRE Respiratory (R) Panel Mini,a second multiplex PCR-based test cleared for use on the BIOFIRE SPOTFIRE System
In August 2023, BD received the US FDA approval for its BD Respiratory Viral Panel (RVP) for BD MAX System, a single molecular diagnostic combination test that identifies &amp; distinguishes SARS-CoV-2, influenza A, influenza B, and Respiratory Syncytial Virus (RSV) in ~ 2 hours.
In December 2023, Thermo Fisher Scientific Inc. and Project HOPE, a leading global health and humanitarian organization, partnered to expand the accessibility of HIV testing services offered by Thermo Fisher among HIV Positive Youth ]]></description>
			<pubDate>Wed, 28 Feb 2024 00:00:00 +0000</pubDate>
			</item>                        
	 </channel></rss>